Beijing Cancer Hospital /ID# 210133

Beijing, Beijing Municipality 100142

0 studies enrolling now · 1 studies all time

What they study most

Non-small Cell Lung Cancer

Studies at this site

• Study of Telisotuzumab Vedotin (ABBV-399) in Participants With Previously Treated c-Met+ Non-Small Cell Lung Cancer — Running, not enrolling